SCHEMBL6013073

SCHEMBL6013073

O=C(O)N1CCCc2cccnc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.48
HDAC6 Q9UBN7 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.46
CYP11B2 P19099 4/20 0.46
GAA P10253 1/20 0.46
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
POLB P06746 2/20 0.45
KDM4E B2RXH2 1/20 0.45
MAPT P10636 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
HSD17B10 Q99714 1/20 0.45
NOTUM Q6P988 1/20 0.44
MTNR1A P48039 1/20 0.44
CRBN Q96SW2 2/20 0.43
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29362288 1.00 HDAC1 (0.48) HDAC1HDAC6SMN1; SMN2CYP11B2GAA
SCHEMBL28604201 0.95 AVPR2 (0.48) HDAC1HDAC6SMN1; SMN2CYP11B2GAA
SCHEMBL29736751 0.90 CRBN (0.51) HDAC1HDAC6SMN1; SMN2CYP11B2MEN1
SCHEMBL18181423 0.90 CRBN (0.51) HDAC1HDAC6SMN1; SMN2CYP11B2MEN1
SCHEMBL29489948 0.86 CYP11B2 (0.61) CYP11B2
SCHEMBL16671108 0.86 CYP11B2 (0.61) CYP11B2
Hydrochloric Acid SCHEMBL30640657 0.84 CYP11B2 (0.60) CYP11B2
SCHEMBL32676351 0.80 MAPT (0.57) SMN1; SMN2GAAMEN1KMT2APOLB
SCHEMBL25921151 0.79 CYP11B2 (0.45) HDAC1HDAC6SMN1; SMN2CYP11B2GAA
SCHEMBL861264 0.79 POLB (0.45) HDAC1HDAC6CYP11B2GAAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1684754-A1 HMG-COA REDUCTASE INHIBITORS AND METHOD Bristol-Myers Squibb Company (US) 2006-08-02 EP disclosed
WO-2005051386-A1 HMG-COA REDUCTASE INHIBITORS AND METHOD BRISTOL-MYERS SQUIBB COMPANY (US) 2005-06-09 WO disclosed